CMMB: Prakiraan wutah bathi saben saham kanggo taun ngarep Chemomab Therapeutics Ltd.

Logo perusahaan publik chemomab.com (CMMB)

The prospects for Chemomab Therapeutics (CMMB) are based on the development of therapies for rare fibrous pathologies, investor support, and orphan drug status. The development of monoclonal antibodies will ensure high margins and patent protection for the drugs. Analyzing the forward earnings per share growth forecast displayed on GURU.Markets, this chart shows that the metric has leveled off at 0.00, taking into account R&D risks and the burn rate.

Chemomab Therapeutics Ltd (CMMB): Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep saka 04.07.2022 nganti 16.11.2026

Rincian analitis lan laporan data perusahaan Chemomab (CMMB)

Pambiji fundamental perusahaan:CMMB, Chemomab Therapeutics Ltd
Produk dadi Chemomab Therapeutics Ltd

Identifying fundamentally resilient assets requires an analysis of consensus forecasts for future returns. This metric measures the expected dynamics of net income per share, reflecting market expectations for capital growth rates. For Chemomab Therapeutics (CMMB), which integrates sustainable ESG standards into drug development, the target net income per share growth rate serves as an indicator of the effectiveness of ethical compliance and cost optimization.

Analisis perusahaan pesaing

VRTX (Vertex) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep ALNY (Alnylam)|Prakiraan wutah bathi saben saham kanggo taun ngarep INSM (Insmed)|UTHR (United Therapeutics Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BioMarin BMRN|BBIO (BridgeBio Pharma Inc) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|BGM Group Ltd - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep COGT (Cogent Biosciences)|XERS: Prakiraan wutah bathi kanggo taun ngarep|Keros Therapeutics Inc (KROS) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Arcturus Pharma|ETON: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep kamada.com (KMDA)|Prakiraan wutah bathi saben saham kanggo taun ngarep Fulcrum Therapeutics FULC|Prakiraan wutah bathi kanggo taun ngarep ABEO (Abeona Therapeutics, Inc.)|Prakiraan wutah bathi kanggo taun ngarep Mereo BioPharma MREO|PLX - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep PLRX|Applied Therapeutics (APLT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Rein Therapeutics Inc (RNTX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Gelteq Limited|AYTU (Aytu BioPharma) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep SRXH (SRx Health Solutions Inc)|PLRZ - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aeterna Zentaris AEZS|Cyclo Therapeutics, Inc. (CYTH) - Prakiraan wutah bathi resik saben saham ing taun ngarep|INZY - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep RPHM (Reneo Pharmaceuticals Inc.)|COSCIENS Biopharma Inc. (CSCI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep